Progress Pulse

Hearing is a gateway to learning for young children treated for cancer

Heather Conklin

Heather Conklin, PhD, St. Jude Division of Neuropsychology chief and St. Jude Department of Psychology and Biobehavioral Sciences member works to understand how to protect childhood cancer survivors’ hearing and neurocognitive health.

Young children treated for brain tumors experience specific treatment-related effects from therapy, including hearing loss. A study led by Heather Conklin, PhD, St. Jude Department of Psychology and Biobehavioral Sciences found that young children (those less than 3 years old) that experience hearing loss also show lower IQs, attention spans and adaptive functioning skills, with the youngest being the most impacted. The results indicate a need for early and frequent hearing assessments and educational interventions in this population to potentially mitigate the effect. The findings were published in Neuro-Oncology

“Given that hearing loss is potentially avoidable with adjustments to cancer treatment and that there are methods to aid hearing and support learning in children who experience hearing loss, these findings offer opportunities to improve cognitive and academic outcomes for our youngest survivors,” said Conklin.

Read more

Recent Progress Pulse Stories

Posterior fossa syndrome linked to lasting neurocognitive challenges in childhood medulloblastoma survivors

Multiple doses of antiviral may improve treatment of severe human H5N1 infection

Study provides framework of a ‘good doctor’ in the art of pediatric oncology

Leveraging a metabolic vulnerability to overcome chemoresistance in recurrent Ewing Sarcoma

Stay ahead of the curve